synthetic semaglutide synthesis novo nordisk EP3398960B1 Semaglutide is an alternative version

GLP-1RAs further lower the risk of stroke indirectly by reducing traditional stroke risk factors such as HbA1c, SBP, body weight, and dyslipidemia

[DOI] [PubMed] [Google Scholar] 233.Soto Conti C.P

In some animal experiments, it has been reported that GLP-1 may be effective in improving inflammation [27,28], postprandial hyperlipidemia [29,30], endothelial cell dysfunction [31], and oxidative stress [32], as well as protecting -cells [33,34]

Its also the same drug class as Wegovy, which is FDA-approved specifically for weight loss

Choosing supplements from reputable brands that prioritize safety and efficacy is essential for seniors considering glutathione supplementation